NCT05520567 2026-03-04A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid LeukemiaAstellas Pharma IncPhase 1/2 Active not recruiting70 enrolled
NCT05209295 2026-01-12A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid MalignanciesBristol-Myers SquibbPhase 1 Terminated2 enrolled